Cancer risk in oil refinery workers: a pooled mortality study in Italy.


Journal

La Medicina del lavoro
ISSN: 0025-7818
Titre abrégé: Med Lav
Pays: Italy
ID NLM: 0401176

Informations de publication

Date de publication:
22 Feb 2019
Historique:
received: 13 11 2018
accepted: 23 01 2019
entrez: 23 2 2019
pubmed: 23 2 2019
medline: 20 7 2019
Statut: epublish

Résumé

Oil refinery workers are exposed to several well-established carcinogens and working in this type of industry has been classified by IARC as probable carcinogen to humans (Group 2A). To examine the mortality experience of workers employed in four Italian oil refineries. The cohort included 5112 male workers ever employed between 1949 and 2011. The average follow-up period was 49 years. Standardized mortality ratios (SMR) and 95% Confidence Intervals (CI) were calculated using as reference age-gender-calendar specific regional rates. Analyses by duration of employment and latency were performed. In the whole cohort, pleural cancer (6 deaths, SMR 1.59; 95% CI 0.71-3.53), brain cancer (14 deaths, SMR 1.47; 95% CI 0.87-2.49) and lymphatic leukemia (LL) (8 deaths, SMR 1.81; 95% CI 0.91-3.62) showed increased risks. All pleural cancers occurred after 10 years of latency and the highest risk was observed among workers with duration ≥20 years; the brain cancer excess was confined in the shortest duration and latency. The LL (and chronic lymphatic leukemia in particular) excess regarded workers with latency and duration longer than 20 years. Four deaths from acute myeloid leukemia (AML) were observed and all occurred after 20 years of latency (SMR 1.55, 95% CI 0.58-4.12); a two-fold-increased risk was observed in the longest duration. No increased risk for skin cancer has been observed in our study population. Our findings are consistent with recent evidence of an increased mortality from pleural and hematopoietic malignancies (AML and LL) among oil refinery workers. However, the lack of individual quantitative exposure data and the small number of observed events prevent the identification of the possible causal role of individual chemicals, including benzene, especially at the current very low exposure levels.

Sections du résumé

BACKGROUND BACKGROUND
Oil refinery workers are exposed to several well-established carcinogens and working in this type of industry has been classified by IARC as probable carcinogen to humans (Group 2A).
OBJECTIVES OBJECTIVE
To examine the mortality experience of workers employed in four Italian oil refineries.
METHODS METHODS
The cohort included 5112 male workers ever employed between 1949 and 2011. The average follow-up period was 49 years. Standardized mortality ratios (SMR) and 95% Confidence Intervals (CI) were calculated using as reference age-gender-calendar specific regional rates. Analyses by duration of employment and latency were performed.
RESULTS RESULTS
In the whole cohort, pleural cancer (6 deaths, SMR 1.59; 95% CI 0.71-3.53), brain cancer (14 deaths, SMR 1.47; 95% CI 0.87-2.49) and lymphatic leukemia (LL) (8 deaths, SMR 1.81; 95% CI 0.91-3.62) showed increased risks. All pleural cancers occurred after 10 years of latency and the highest risk was observed among workers with duration ≥20 years; the brain cancer excess was confined in the shortest duration and latency. The LL (and chronic lymphatic leukemia in particular) excess regarded workers with latency and duration longer than 20 years. Four deaths from acute myeloid leukemia (AML) were observed and all occurred after 20 years of latency (SMR 1.55, 95% CI 0.58-4.12); a two-fold-increased risk was observed in the longest duration. No increased risk for skin cancer has been observed in our study population.
CONCLUSION CONCLUSIONS
Our findings are consistent with recent evidence of an increased mortality from pleural and hematopoietic malignancies (AML and LL) among oil refinery workers. However, the lack of individual quantitative exposure data and the small number of observed events prevent the identification of the possible causal role of individual chemicals, including benzene, especially at the current very low exposure levels.

Identifiants

pubmed: 30794243
doi: 10.23749/mdl.v110i1.7842
pmc: PMC7810000
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3-10

Références

IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt F):9-562
pubmed: 23189753
Br J Cancer. 2014 Feb 4;110(3):783-7
pubmed: 24357793
Environ Health Perspect. 2011 Feb;119(2):159-67
pubmed: 20880796
IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt E):1-538
pubmed: 23193840
Cancer Epidemiol. 2010 Oct;34(5):516-22
pubmed: 20561834
J Occup Environ Med. 2000 May;42(5):554-68
pubmed: 10824308
Am J Ind Med. 2012 Sep;55(9):779-85
pubmed: 22729623
Am J Ind Med. 2000 Mar;37(3):275-82
pubmed: 10642417
Lancet Oncol. 2009 Dec;10(12):1143-4
pubmed: 19998521
Saf Health Work. 2011 Mar;2(1):26-33
pubmed: 22953184
Environ Health. 2010 Jun 28;9:31
pubmed: 20584305
Environ Health Perspect. 1996 Dec;104 Suppl 6:1381-92
pubmed: 9118924
Br J Haematol. 2007 Dec;139(5):672-86
pubmed: 18021081
Int Arch Occup Environ Health. 1989;61(4):261-70
pubmed: 2722249
J Occup Environ Med. 2007 May;49(5):557-67
pubmed: 17495698
Am J Ind Med. 1999 Mar;35(3):287-94
pubmed: 9987562
IARC Monogr Eval Carcinog Risks Hum. 1989;45:1-322
pubmed: 2664246
Med Lav. 2010 May-Jun;101(3):189-98
pubmed: 20812660
Occup Environ Med. 2008 Jun;65(6):371-8
pubmed: 18417556
Arch Environ Health. 2004 Apr;59(4):188-93
pubmed: 16189991
Regul Toxicol Pharmacol. 2000 Aug;32(1):78-98
pubmed: 11029272
Occup Environ Med. 2000 Sep;57(9):595-604
pubmed: 10935940
Occup Med (Lond). 2007 May;57(3):177-85
pubmed: 17244595

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH